Influence of coacervation-inducing agents and cooling rates on the preparation andin vitrorelease of bleomycin hydrochloride microcapsules
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 2 (2) , 91-101
- https://doi.org/10.3109/02652048509031553
Abstract
Two types of coacervation-inducing agents (EVA, PIB) and three cooling rates (0.01998, 0.03482 and 0.06725 degrees C/min) affecting the preparation, micromeritic and drug release properties of bleomycin hydrochloride microcapsules were investigated. Particle size distribution of microcapsules induced by EVA significantly depended on the cooling rate, but that induced by PIB was independent of the cooling rate. Higher viscosity of PIB led to a smaller particle size of microcapsules than when EVA was used. The surface topography of the microcapsules for both types of coacervation-inducing agents was obviously different. We found that the release behaviour of bleomycin hydrochloride from the microcapsules also depended on the type of coacervation-inducing agent and the cooling rate. In general, the slower the cooling rate the more prolonged the release of the drug. Higuchi matrix model was followed for bleomycin hydrochloride released from the microcapsules. T50 of both types of microcapsules decreased with the increase of the cooling rate. To simulate the absorption behaviour of the GI tract, the continuous flow dialysis method was modified for drug release from the microcapsules. The data indicate that the diffusion of the dissolution medium and dissolved drug through the ethylcellulose wall of the microcapsules is the rate-limiting step before dialysis. This also implies that the release rate of the drug from dosage form significantly determined the absorption in the GI tract.Keywords
This publication has 11 references indexed in Scilit:
- Drug Release Properties of the Microcapsules of Adriamycin Hydrochloride with Ethylcellulose Prepared by a Phase Separation TechniqueDrug Development and Industrial Pharmacy, 1984
- Bleomycin in the treatment of recalcitrant wartsJournal of the American Academy of Dermatology, 1983
- Transcatheter Arterial Chemoembolization of Renal Cell Carcinoma with Microencapsulated Mitomycin CJournal of Urology, 1981
- Sustained-release properties of microencapsulated mitomycin C with ethylcellulose infused into the renal artery of the dogCancer, 1980
- The effects of wall thickness and amount of hardening agent on the release characteristics of sulfamethoxazole microcapsules prepared by gelatin-acacia complex coacervation.CHEMICAL & PHARMACEUTICAL BULLETIN, 1979
- Local Injection of Oil Bleomycin for Malignant Tumors of the Head and NeckPractica Oto-Rhino-Laryngologica, 1976
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973
- Treatment of malignant lymphomas with bleomycinCancer, 1972
- Bleomycin Treatment of the Tumors of Penis and ScrotumJournal of Urology, 1969
- Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJournal of Pharmaceutical Sciences, 1963